Description
Using our intelligently designed and intuitive dataset, you can quickly understand how Medtronic (MDT) is lobbying the U.S. government, how much they’re spending on it, and most importantly – the bills and specific issues on which they lobby.
Gain an informational edge with our Lobbying Data Intelligence. Perform analysis by company, lobbyist, lobbying firm, government agency, or issue.
For lobbying firms: understand your competitors. Understand who is registering with who. Gain insight on quarterly reports and specific issues other firms are lobbying on.
Our lobbying data is collected and aggregated from the U.S. Senate Office of Public Records from 1999-present and is updated on a regular basis. We utilize advanced data science techniques to ensure accurate data points are collected and ingested, match similar entities across time, and tickerize publicly traded companies that lobby.
Our comprehensive and advanced lobbying database is completed with all the information you need, with more than 1.6 million lobbying contracts ready-for-analysis. We include detailed information on all aspects of federal lobbying, including the following fascinating attributes, among much more:
1. Clients: The publicly traded company, privately owned company, interest group, NGO, or state or local government that employs or retains a lobbyist or lobbying firm.
2. Registrants (Lobbying Firms): Either the name of the lobbying firm hired by the client, or the name of the client if the client employs in-house lobbyists.
3. Lobbyists: The names and past government work experience of the individual lobbyists working on a lobbying contract. 3. General Issues: The general issues for which clients lobby on (ex: ENV – Environment, TOB – Tobacco, FAM – Family Issues/Abortion).
4. Specific Issues: A long text description of the exact bills and specific issues for which clients lobby on.
5. Bills Lobbied On: The exact congressional bills and public/private laws lobbied on, parsed from lobbying report specific issues (ex: H.R. 2347, S. 1117, Tax Cuts and Jobs Act).
6. Agencies Lobbied: The names of one or more of 250+ government agencies lobbied on in the contract (ex: White House, FDA, DOD).
7. Foreign Entities: The names and origin countries of entities affiliated with the client (ex: BNP Paribas: France).
Gain access to our highly unique and actionable U.S. lobbying database. Further information on LobbyingData.com and our alternative datasets and database can be found on our website, or by contacting [email protected].
Frequently Asked Questions
What is Medtronic (MDT) lobbying for?
The following is a summary of the Medtronic lobbying data:
– Lobbying firms hired: Inc., Ernst & Young Llp (Washington Council Ernst & Young), Inc., Mehlman Consulting, Llc, Government Counsel
– General issues they lobbied on: Taxation/Internal Revenue Code, Government Issues, Telecommunications, Labor Issues/Antitrust/Workplace, Health Issues, Environment/Superfund, Veterans, Consumer Issues/Safety/Products, Medicare/Medicaid, Copyright/Patent/Trademark, Trade (domestic/foreign), Budget/Appropriations
– Specific issues they lobbied on: pertaining to cyber security of medical devices, issues related to the sterilization of medical devices, issues related to servicing and repair of medical devices, support for the Cardiovascular Advances in Research and Opportunity Legacy (CAROL) Act (H.R. 1193 and S. 1133), issues related to Cancer Moonshot proposals, VA debts subject to offset in the SAM system., Consolidated Appropriations Act, Public Law 117-328-Consolidated Appropriations Act, H.R.7667 – Food and Drug Amendments of 2022, issues related to the taxation of multinational corporations (H.R. 5376), including H.R. 5932 – Inpatient Opioid Safety Act of 2021, issues related to disparities of care, issues pertaining to FDA included in P.L. 117-328, and H.R. 7084/A. 3983 -Patch Act of 2022, Supporting Medicare Providers Act of 2022; H.R.2617, monitoring H.R. 7185, Physician payment and policy issues relating to peripheral arterial disease and other cardiovascular issues; Amputation Reduction and Compassion Act, Medicare Physician Fee Schedule; Medicare Physician Fee Schedule reform; ; H.R. 8800, Inflation Reduction Act, including H.R. 5932 – Inpatient Opioid Safety Act of 2021, issues related to disparities of care, issues pertaining to FDA, relating to S. 4348 (FDASLA Act of 2022), monitoring P.L. 117-263, 21st Century Cures 2.0, H.R.1193: Cardiovascular Advances in Research and Opportunities Legacy (CAROL) Act, S.4348: FDASLA Act of 2022 and H.R.7667: Food and Drug Amendments of 2022, H.R.7084: PATCH Act of 2022, H.R.9067: Better Interoperability for Devices (BID) Act, S.3799 – PREVENT Pandemics Act, S.4391 – CLEAR Documentation Act – regarding certificates to foreign government., issues related to intellectual property, issues related to patents, issues related to copyrights, issues related to H.R. 6000, S.3799 (PREVENT Pandemics Act), social and governance (ESG) issues relating to the health sector, issues related to global supply chains, issues related to US-China trade, issues related to the Trade-Related Aspect
– Government agencies they lobbied: House of Representatives, Department of Health & Human Services (HHS), Senate, Centers For Medicare and Medicaid Services (CMS), Department of Commerce (DOC)
One could infer that Medtronic is lobbying on a wide range of issues related to healthcare policies and regulations, including Medicare and Medicaid, FDA approval processes and regulation, intellectual property, taxation and trade issues. The lobbying efforts may be aimed at promoting the interests of the company, such as expanding its market share, increasing profitability, or preventing competition. Additionally, Medtronic may be advocating for increased access to healthcare products and services or advocating for policies that incentivize innovation and technological advancements.
